Acute Myeloid Leukemia with Other Genetic Abnormalities

Acute Myeloid Leukemia with Other Genetic Abnormalities — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 50%
Top sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01578109	Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia	completed	Phase 1	51	National Cancer Institute (NCI)NIH	1	Apr 2, 2024	clinicaltrials

Data updated 23 days agoSource updated Apr 2, 2024source: clinicaltrials